Clinical Trial Update: Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial using large-scale metabolomic profiling for diagnosing congenital disorders of glycosylation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Disorders of Glycosylation

Snippet

Sponsor: Mayo Clinic | Conditions: Congenital Disorders of Glycosylation | Status: COMPLETED